Penn National Gaming, Inc. (PENN:Nasdaq) announced that it will release its 2014 fourth quarter financial results at 7:00 a.m. ET on Thursday, January 29, 2015 and will host a conference call and simultaneous webcast at 10:00 a.m. ET on Thursday, January 29, 2015. On Wednesday shares of Penn National Gaming Inc. (NASDAQ:PENN) closed at $15.42. Company’s sales growth for last 5 years was 3.80% and EPS growth for next 5 years is recorded as 5.00%.
Advanced Micro Devices, Inc. (NYSE:AMD) disclosed the unveiling of embedded Radeon HD 7850 GPU for medical imaging system. The new emdedded GPUt would allow for advanced application function for the BK Ultrasound influenced by Analogic, bk3000 ultrasound systems. The company believes that the embedded Radeon offered an efficient, as well as, powerful pairing. Advanced Micro Devices, Inc. (NASDAQ:AMD) in last trading activity decreased -1.13% to close at $2.63. Company weekly performance is 1.94% while its quarterly performance stands at 0.38%. Advanced Micro Devices, Inc. (NASDAQ:AMD) is -45.21% away from its 52 week high.
On January 9, The Advisory Board Company (NASDAQ:ABCO) a global insight-driven technology, research, and services provider, announced the completion of its acquisition of Royall & Company (“Royall”). The transaction was first announced on December 10, 2014. On last trading day The Advisory Board Company (NASDAQ:ABCO) decreased -0.70% to close at $48.04. Its volatility for the week is 3.68% while volatility for the month is 3.92%. ABCO’s sales growth for past 5 years was 18.50% and its EPS growth for past 5 years was 0.30%. The Advisory Board Company (NASDAQ:ABCO) monthly performance is 4.39%.
UFP Technologies, Inc. (NASDAQ:UFPT) has received a Neutral rating, according to the latest rank of 3 from research firm, Zacks. The counter could manage an average rating of 1 from 2 analysts. 2 market experts have complete faith in the companys business and have marked it as a strong buy. UFP Technologies, Inc. (NASDAQ:UFPT) has 9.30% insider ownership while its institutional ownership stands at 61.80%. In last trading activity company’s stock closed at $24.61.
Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) cash dividend payment of $0.1 per share is scheduled to be paid on January 28, 2015. Shareholders who purchased ENZN stock prior to the ex-dividend date are eligible for the cash dividend payment. On Wednesday shares of Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) closed at $0.98. Company’s sales growth for last 5 years was -9.60%.